IRIS
ALTIERI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.300
AS - Asia 273
SA - Sud America 40
NA - Nord America 30
AF - Africa 4
Totale 8.647
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.293
SG - Singapore 111
CN - Cina 76
VN - Vietnam 59
BR - Brasile 21
US - Stati Uniti d'America 20
AR - Argentina 14
MX - Messico 9
HK - Hong Kong 7
ID - Indonesia 5
BD - Bangladesh 4
EC - Ecuador 3
IQ - Iraq 3
PK - Pakistan 3
RU - Federazione Russa 3
DE - Germania 2
TN - Tunisia 2
BG - Bulgaria 1
CO - Colombia 1
EG - Egitto 1
IN - India 1
JP - Giappone 1
KR - Corea 1
MA - Marocco 1
PA - Panama 1
TH - Thailandia 1
UA - Ucraina 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 8.647
Salva come PNG Salva come JPEG
Città #
Genova 4.584
Genoa 2.178
Rapallo 915
Vado Ligure 591
Singapore 42
Bordighera 24
Beijing 22
Ho Chi Minh City 22
Hanoi 15
Mexico City 8
Hong Kong 7
Da Nang 6
Ashburn 5
Council Bluffs 4
Boardman 3
Chongqing 3
Haiphong 3
São Paulo 3
Tianjin 3
Buenos Aires 2
Chicago 2
Clayton 2
Guangzhou 2
Mauá 2
Quảng Ngãi 2
São Bernardo do Campo 2
Tunis 2
Alexandria 1
Arroio Grande 1
Bahía Blanca 1
Biên Hòa 1
Brasília 1
Bắc Ninh 1
Campo Viera 1
Can Tho 1
Caracas 1
Cariacica 1
Casablanca 1
Chennai 1
Chernivtsi 1
Clorinda 1
Cotia 1
Curitiba 1
Córdoba 1
Dhaka 1
Diyālá 1
Ensenada 1
Faxinal do Soturno 1
Guarulhos 1
Guayaquil 1
Haikou 1
Hamburg 1
Isidro Casanova 1
Jandira 1
Jeonju 1
Karbala 1
Kumamoto 1
Lahore 1
Las Toscas 1
Long An 1
Los Angeles 1
Lấp Vò 1
Macaé 1
Magelang 1
Maipú 1
Makhachkala 1
Mendoza 1
Nanyang 1
Ninh Bình 1
Nuremberg 1
Nārāyanganj 1
Panama City 1
Passo Fundo 1
Petrolina 1
Phủ Lý 1
Ponte Nova 1
Qina 1
Quilmes 1
Quito 1
Rawalpindi 1
San Fernando 1
Santa Clara del Mar 1
Santa Rosa 1
Shantou 1
Sinop 1
Sofia 1
Sorocaba 1
Surakarta 1
Sóc Trăng 1
Tampa 1
Tashkent 1
Villavicencio 1
Wuhan 1
Yaroslavl 1
Zhengzhou 1
Totale 8.522
Salva come PNG Salva come JPEG
Nome #
Cell-cell bond modulates vascular smooth muscle cell responsiveness to Angiotensin II 208
Acute coronary syndromes do not promote prolonged in vivo FXII-dependent prothrombotic activity 203
Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes 202
The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity 201
Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions. 201
CD16+ monocyte subsets are increased in large abdominal aortic aneurysms and are differentially related with circulating and cell-associated biochemical and inflammatory biomarkers. 187
C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians 179
Data regarding the effects of thrombin and dabigatran-inhibited thrombin on protease-activated receptor 1 and activation of human atrial fibroblasts 179
Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects 174
ALTERED CELL-FUNCTION ASSOCIATED TO LOSS OF CELL-MATRIX ADHESION: PRELIMINARY DATA ON A RAT AORTIC SMOOTH MUSCLE CELL LINE 170
Moderate increase of indoxyl sulfate promotes monocyte transition into profibrotic macrophages 169
Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2 167
Sublethal Doses of an Anti-erbB2 Antibody Leads to Death by Apoptosis in Cardiomyocytes Sensitized by Low Prosenescent Doses of Epirubicin: The Protective Role of Dexrazoxane. 162
CYBA polymorphism associated with oxidative stress in Italian patients with early onset of coronary artery disease. 158
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. 156
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis 155
Carvedilol prevents mitochondrial membrane potential loss induced by doxorubicin in cardiomyocytes 140
Cyba polymorphism associated to oxidative stress in italian patients with early onset coronary artery disease. 4th meeting of the ETRO working party on population genetics of haemostatic risk factors for arterial vascular disease 139
Protective effects of carvedilol against doxorubicin-induced apoptosis in cardiac muscle cells 136
Controllo antagonista di p38 e JNK nella regolazione della senescenza e di p16INK4A indotte dalla doxorubicina nei progenitori delle cellule endoteliali 132
Attivazione del fattore coagulativo XII in pz con angina stabile ed instabile 131
SOLUBLE FORM OF THE ENDOTHELIAL ADHESION MOLECULECD146 BINDS PREFERENTIALLY PROINFLAMMATORYPROATHEROSCLEROTICCD16+ MONOCYTE SUBSET 131
BASSE DOSI DI DOXORUBICINA PORTANO I CARDIOMIOCITI A MORTE TARDIVA PER CATASTROFE MITOTICA DOVUTA AD UNA ALTERATA REGOLAZIONE DELLE PROTEINE DEL TELOMERO: RUOLO DELLE MAPKs E DI p53 130
ADVANCED ABDOMINAL AORTIC ANEURYSMS DISPLAY ASPECIFIC INFLAMMATORY-PROATHEROSCLEROTIC PROFILEWITH RENAL DYSFUNCTION, RAISED D-DIMER, EXPANDEDCD14++CD16+-MONOCYTES HAVING HIGH CD143 130
Early Age of onset of unstable angina is associated to major oxidative stress 129
Matrix metalloproteinase-2 and-9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase 127
Comparison between the potential protective mechanisms of carvedilol and atenolol against doxorubicin induced cardiac muscle cell damage and death in vitro. 124
Autoanticorpi contro proteine ossidate in pazienti con recente sviluppo di angina instabile. 123
HETEROGENEITY AND DIFFERENT RELATIONSHIP WITH BIOCHEMICAL AND INFLAMMATORY BIOMARKERS FOR THE CIRCULATING CD16+ MONOCYTES SUBSETS IN ABDOMINAL AORTIC ANEURYSMS (AAA) 122
Plasmatic Levels of metalloproteinases 2 and 9 are increased in patients with congestive heart failure. 117
Systemic levels of oxidative stress and title of autoantibodies in patients with ischemic heart disease at their first clinical manifestation. 117
Role of cell-cell bond for the viability and the function of vascular smooth muscle cells. 113
Confronto fra meccanismi potenzialmente protettivi di carvedilolo e atenololo contro il danno e la morte di cellule muscolari cardiache indotti dalla doxorubicina in vitro. 113
Postprandial serum induces apoptosis in endothelial cells: role of plymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity 111
Doxorubicin impairs the insulin-like growth factor-1 axis in H9c2 cells 110
Effects of the AhR inhibitor CH-223191 on the indoxyl sulphateinduced cardiac fibroblast activation. Role of Nrf2 108
Elevated plasma levels of lipid peroxidation are associated to an early onset of UA 108
Doxorubicin promotes metalloproteinases-2 trancriptional and zymographic activity in cardiac muscle cells via Nadph oxidase-derived reactive oxygen species. 103
Plasma Levels of matrix metalloproteinase-9 and matrix metalloproteinase-2 are increased in plasma of patients with heart failure 102
Osteopontin plasma levels correlate with coronary atherosclerosis extension and in-stent restenosis in coronary artery disease patients undergoing percutaneous coronary intervention 101
UN PASTO IPERLIPIDICO INDUCE STRESS OSSIDATIVO DERIVATODALL’ATTIVITÀ DELLA MIELOPEROSSIDASI E DETERMINA L’AUMENTO DELL’ATTIVITÀ DELLE METALLOPROTEASI 101
Plasma Levels of Matrix metalloproteinase-2 are increased in plasma of patients with heart failure. 98
The human fetal and adult stem cell secretome can exert cardioprotective paracrine effects against cardiotoxicity and oxidative stress from cancer treatment 98
Protection against chemotherapy cardiotoxicity by the human amniotic fluid stem cell secretome: a new tool for future paracrine therapy 97
La doxorubicina induce nei cardiomiociti la metalloproteasi di tipo 2 attraverso le specie reattive dell’ossigeno prodotte dalla NADPH ossidasi. 93
Doxorubicin induces activation of Metalloproteinase-2 and –9 in cardiomyocytes through the MAPKinase pathways: protective effects of carvedilol and dexrazoxane 93
Traditional risk factors for ATS do not explain major oxidative stress levels in patients with early age onset of unstable angina: possibile role for genetic factors? Population genetics of haemostatic risk factors for arterial vascular disease. 89
La doxorubicina induce apoptosi e senescenza nei progenitori delle cellule endoteliali e regola l'azione chemiotattica dei cardiomiociti nei loro confronti 89
IL SIERO POSTPRANDIALE MOSTRA EFFETTI PRO-OSSIDANTI E PROAPOPTOTICI SULLE CELLULE ENDOTELIALI 86
Markers of oxidative stress evaluated in patients with ischemic heart disease at the time of their first clinical manifestation. 85
Relazione tra Stress Parietale e Risposta Infiammatoria Sistemica con Danno Miocardico in pazienti con Insufficienza Cardiaca Cronica in fase Stabile 85
Insorgenza precoce di angina instabile e livelli plasmatici di perossidazione lipidica 85
Il carvedilolo previene la perdita del potenziale di membrana mitocondriale indotta da doxorubicina nei cardiomiociti 85
Un pasto iperlipidico rende il siero pro-apoptotico per le cellule endoteliali: ruolo dell’infiammazione e stress ossidativo. 84
Il carvedilolo previene la formazione di radicali liberi e il danno ossidativo indotto da doxorubicina sui cardiomiociti. 83
Scouting in silico different chemo-types of PDE4 inhibitors to guide the design of new anti-inflammatory/antioxidant agents 82
STRESS OSSIDATIVO E P53 MEDIANO L’INIBIZIONE DI IGF-1R INDOTTA DA DOXORUBICINA IN CELLULE MUSCOLARI CARDIACHE 82
Il carvedilolo protegge le cellule endoteliali contro la produzione di radicali liberi e l’apoptosi indotte da doxorubicina. 82
Ruolo del Polimorfismo C242T della Subunità p22phox del Complesso NAD(P)H Ossidasi in Pazienti con Aterosclerosi Coronarica. 82
Meccanismi di tossicità indotta da doxorubicina su cardiomiociti e razionale per l’uso dei farmaci protettivi nella pervenzione del danno cardiaco 80
Elevata attivita’ di metalloprteasi 2 e 9 circolanti nei pazienti con scompenso cardiaco 80
Pensieri radicali: associazione di danno ossidativo proteico con angina instabile di recente insorgenza 80
Pazienti con manifestazione precoce di angina instabile non presentano correlazioni tra livelli di stress ossidativo e autoanticorpi diretti contro proteine ossidate. 78
Inside the Mechanism of Action of Three Pyrazole Derivatives in Human Platelets and Endothelial Cells 74
Polimorfismo nel gene cyba: possibile marcatore di suscettibilita’ genetica all’aterosclerosi 72
La doxorubicina induce le metalloproteasi 2 e –9 attraverso l’attivazione delle MAPK: ruolo protettivo del carvedilolo e del dexrazoxane., 71
TRATTAMENTI SEQUENZIALI CON DOSI SUB-APOPTOTICHE DI EPIDOXORUBICINA ED ANTICORPO ANTI erbB2 INDUCONO APOPTOSI NEI CARDIOMIOCITI: RUOLO CARDIOPROTETTIVO DEL DEXRAZOXANE. 70
Neutrophil-derived matrix metalloproteinase 9 is increased in patients with heart failure 68
Oxaprozin reduces metalloproteinase-9 expression and activity in immune-complex activated human monocytes. 66
Effetto protettivo del carvedilolo contro la morte per apoptosi indotta da doxorubicina in cellule muscolari cardiache. 66
SUBSET MONOCITARI CD14 CD16 IN PAZIENTI CON SCOMPENSO CARDIACO CONGESTIZIO. 65
La doxorubicina induce l’aumento della trascrizione e dell’attività della MMP-2 nelle cellule muscolari cardiache attraverso le specie reattive dell’ossigeno prodotte dalla NADPH ossidasi. 60
La metalloproteasi di tipo 9 proveniente dai neutrofili aumenta nei pazienti con scompenso cardiaco. 56
IL LEGAME CELLULA-CELLULA CONTRASTA GLI EFFETTI PROATEROGENICI DI ANGIOTENSINA II IN CELLULE MUSCOLARI LISCE DI AORTA DI RATTO 56
RIDOTTA APOPTOSI DEI LEUCOCITI POLIMORFONUCLEATI EDANNO ENDOTELIALE IN SOGGETTI AFFETTI DA SCOMPENSO CARDIACO CONGESTIZIO 56
Le risposte infiammatorie ed ossidative indotte da un pasto iperlipidico rendono il siero postprandiale proapoptotico per le cellule endoteliali. 54
UN PASTO AD ALTO CONTENUTO LIPIDICO DIMINUISCE IL TASSO DI APOPTOSI SPONTANEA DEI LEUCOCITI POLIMORFONUCLEATI 52
Indoxyl sulphate-initiated activation of cardiac fibroblasts is modulated by aryl hydrocarbon receptor and nuclear factor-erythroid-2-related factor 2 45
Bronchoalveolar Lavage Derived Fibroblasts From Interstitial Lung Disease Patients: A Chance to Exploit 2D/3D Model of Pulmonary Fibrosis In Vitro 11
Totale 8.707
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.185
article - articoli 22.454
book - libri 0
conference - conferenze 4.731
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.370
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021193 0 0 0 0 0 31 8 27 42 31 25 29
2021/2022848 8 69 62 112 53 41 47 211 19 88 32 106
2022/20231.077 102 71 9 107 210 162 10 84 181 8 114 19
2023/2024505 15 59 9 55 45 109 24 33 57 8 24 67
2024/20251.487 64 103 44 111 196 131 132 227 51 86 157 185
2025/20261.010 335 64 119 191 272 29 0 0 0 0 0 0
Totale 8.707